FUMOM is a combination of Mometasone Furoate cream that is used to treat skin conditions like allergies, eczema, rashes, and other complications related to it. This cream belongs to a group of drugs called topical corticosteroids. Mometasone Furoate cream is very useful in getting relief from various skin conditions like itching, inflammation, and many more. This cream works by blocking the action of certain chemicals that causes inflammation or rashes on the body. When used correctly and effectively it helps to get relief from itchy patches on elbows, knees.
Precautions for Mometasone Furoate Cream
Mometasone Furoate cream is to be used on a washed and dried area of the body with clean hands. Spread it as a thin layer on the affected area in the prescribed quantity. Avoid any kind of contact with eyes, nose, or mouth to avoid any wrong consequences.
Side effects of Mometasone Furoate Cream
Mometasone Furoate cream doesn’t cause any major side effects and accordingly, they don’t require any medical emergency, but if they don’t go away with time then contact the doctor right away.
- Skin Atrophy
- Paresthesia (tingling sensation)
- Stinging sensation
Contact for Mometasone Furoate Cream Manufacturing And Supply
Gnova Biotech has left a benchmark on the Pharma Industry with its DCGI & FSSAI approved products. Being an ISO-certified company it serves all of its clients in a very good way. We are perceived as the Best Mometasone Furoate Cream manufacturer and supplier in India. We make sure to provide our associates with the best possible services so that both of us can grow together. We also provide PCD Pharma Franchise for Mometasone Furoate cream across India.
- Our company gives complete and exclusive monopoly rights to all of its associates.
- We make sure to provide our pharma products at a very nominal rate so that every one can buy them.
- All of our machines and production facilities are lubricated at regular intervals.
- We make sure to adhere to all the guidelines of WHO & GMP.
Reviews
There are no reviews yet.